Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Immunology Letters|June 18, 2002
Co-expression of the CD8 receptor in a human CD4+ T-cell clone influences proliferation, cytosolic Ca2+ release and cytokine productionMonica Molteni, Leonard D Kohn, Carlo Rossetti, et al.
The Journal of Experimental Medicine|May 24, 2006
A cyanobacterial LPS antagonist prevents endotoxin shock and blocks sustained TLR4 stimulation required for cytokine expressionAnnalisa Macagno, Monica Molteni, Andrea Rinaldi, et al.
Cell and Tissue Research|March 29, 2019
The medicinal leech as a valuable model for better understanding the role of a TLR4-like receptor in the inflammatory processRossana Girardello, Nicolò Baranzini, Monica Molteni, et al.
Biochemical and Biophysical Research Communications|September 19, 2006
alpha-Synuclein protects SH-SY5Y cells from dopamine toxicityMonica Colapinto, Silvia Mila, Sabrina Giraudo, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 11, 2011
Structural investigation and biological activity of the lipooligosaccharide from the psychrophilic bacterium Pseudoalteromonas haloplanktis TAB 23Sara Carillo, Giuseppina Pieretti, Ermenegilda Parrilli, et al.
Nature Medicine|March 30, 2010
Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizuresMattia Maroso, Silvia Balosso, Teresa Ravizza, et al.
Brain, Behavior, and Immunity|October 19, 2016
Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by β-amyloid oligomers in an acute mouse model of Alzheimer's diseaseClaudia Balducci, Angelisa Frasca, Margherita Zotti, et al.
Molecular Medicine (Cambridge, Mass.)|May 8, 2012
Neuroprotective effects of toll-like receptor 4 antagonism in spinal cord cultures and in a mouse model of motor neuron degenerationMassimiliano De Paola, Alessandro Mariani, Paolo Bigini, et al.
Neurobiology of Disease|December 13, 2016
Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsyValentina Iori, Anand M Iyer, Teresa Ravizza, et al.
Pageof 2